Transepithelial potential difference in the bronchial system of children with chronic bronchitis and bronchial asthma

E H Ballke1, S Wiersbitzky, A König

  • 1Klinik für Kinder- und Jugendmedizin, Ernst-Moritz-Arndt-Universität, Greifswald, Germany.

Padiatrie Und Grenzgebiete
|January 1, 1992
PubMed

Insights

Transepithelial potential difference (tpd) varied significantly in children with chronic respiratory diseases. Higher tpd in asthmatics correlated with eosinophils, suggesting their role in respiratory tract changes.

Area of Science:

  • Pediatric Pulmonology
  • Respiratory Physiology

Background:

  • Chronic non-specific respiratory diseases (CNSRD) encompass conditions like bronchial asthma and chronic bronchitis in children.
  • Understanding the physiological differences between these conditions is crucial for accurate diagnosis and treatment.

Purpose of the Study:

  • To investigate the transepithelial potential difference (tpd) in the tracheobronchial system of children with CNSRD.
  • To explore potential correlations between tpd measurements and specific disease characteristics, such as eosinophilia.

Main Methods:

  • Transepithelial potential difference (tpd) was measured in the tracheobronchial system of 45 children (18 with asthma, 27 with bronchitis) via bronchoscopy under general anesthesia.
  • Bronchial secretions were analyzed for eosinophil presence.

Main Results:

  • A highly significant statistical variation in tpd was observed among the children.
  • Children with asthma and significant eosinophilia in bronchial secretions exhibited a higher mean tpd (26.5 ± 8.5 mV) compared to children with bronchitis (18.2 ± 6.3 mV).

Conclusions:

  • Transepithelial potential difference (tpd) measurements show significant variation in pediatric chronic respiratory diseases.
  • The presence of eosinophils in bronchial secretions appears to be associated with altered tpd in asthmatic children, suggesting a role in the pathophysiology of respiratory tract changes.

Related Concept Videos

Chronic Obstructive Pulmonary Disease-II: Pathophysiology01:20

Chronic Obstructive Pulmonary Disease-II: Pathophysiology

Chronic Obstructive Pulmonary Disease (COPD) pathophysiology is intricate and multifaceted, involving a complex interplay of physiological processes. Understanding these mechanisms is crucial for effectively managing and treating COPD. Here is an in-depth look at the critical elements in the pathophysiology of COPD:
Chronic Inflammation
Asthma-II: Pathophysiology and Classification01:26

Asthma-II: Pathophysiology and Classification

Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Asthma I: Introduction01:28

Asthma I: Introduction

Asthma is a chronic inflammatory disorder of the airways characterized by variable airflow obstruction and heightened bronchial responsiveness to a wide range of triggers. The underlying inflammation leads to airway swelling, mucus hypersecretion, and smooth muscle constriction, all of which narrow the airway lumen and impede airflow. Clinically, asthma presents with recurrent episodes of wheezing, shortness of breath, chest tightness, and coughing, symptoms that typically vary in intensity and...
Chronic Obstructive Pulmonary Disease I: Introduction01:23

Chronic Obstructive Pulmonary Disease I: Introduction

Chronic obstructive pulmonary disease is a common, preventable, and treatable respiratory disorder characterized by persistent symptoms and progressive airflow limitation. This limitation results from a combination of small-airway disease (obstructive bronchiolitis) and parenchymal destruction (emphysema), both driven by chronic inflammation from exposure to harmful particles or gases.The disease includes two main pathological entities: emphysema, marked by destruction of alveolar walls and...
Chronic Obstructive Pulmonary Disease II: Emphysema01:23

Chronic Obstructive Pulmonary Disease II: Emphysema

Emphysema, a major phenotype of chronic obstructive pulmonary disease (COPD), is characterized by irreversible destruction of alveolar walls and permanent enlargement of distal airspaces. Unlike chronic bronchitis, which primarily affects the airways, emphysema predominantly involves the lung parenchyma, where structural damage leads to airflow limitation.PathophysiologyIt most commonly results from prolonged exposure to cigarette smoke and other toxic gases, particularly cigarette smoke.
Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features01:24

Chronic Obstructive Pulmonary Disease III: Chronic Bronchitis Features

Chronic bronchitis is a key phenotype of chronic obstructive pulmonary disease (COPD), characterized by airway-centered inflammation and mucus overproduction. It develops from long-term exposure to harmful particles or gases, most commonly cigarette smoke, which triggers a persistent inflammatory response.Cellular and Structural ChangesInflammation initially affects the large bronchi and later the smaller airways, with infiltration by immune cells, including neutrophils, macrophages, and...